|
1
|
Menter A, Gottlieb A, Feldman SR, Van
Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA,
et al: Guidelines of care for the management of psoriasis and
psoriatic arthritis: Section 1. Overview of psoriasis and
guidelines of care for the treatment of psoriasis with biologics. J
Am Acad Dermatol. 58:826–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oka A, Mabuchi T, Ozawa A and Inoko H:
Current understanding of human genetics and genetic analysis of
psoriasis. J Dermatol. 39:231–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Griffiths CE, Christophers E, Barker JN,
Chalmers RJ, Chimenti S, Krueger GG, Leonardi C, Menter A, Ortonne
JP and Fry L: A classification of psoriasis vulgaris according to
phenotype. Br J Dermatol. 156:258–262. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsoi LC, Spain SL, Knight J, Ellinghaus E,
Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, et al:
Identification of 15 new psoriasis susceptibility loci highlights
the role of innate immunity. Nat Genet. 44:1341–1348. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nestle FO, Kaplan DH and Barker J:
Psoriasis. N Engl J Med. 361:496–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Capon F, Di Meglio P, Szaub J, Prescott
NJ, Dunster C, Baumber L, Timms K, Gutin A, Abkevic V, Burden AD,
et al: Sequence variants in the genes for the interleukin-23
receptor (IL23R) and its ligand (IL12B) confer protection against
psoriasis. Human Genetics. 122:201–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang YT, Chou CT, Yu CW, Lin MW, Shiao
YM, Chen CC, Huang CH, Lee DD, Liu HN, Wang WJ and Tsai SF:
Cytokine gene polymorphisms in Chinese patients with psoriasis. Br
J Dermatol. 156:899–905. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Magalhães RF, Biral AC, Pancoto JA, Donadi
EA, Mendes CT Jr, Magna LA and Kraemer MH: Human leukocyte antigen
(HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis
factor (TNF)-alpha −238 and −308 as genetic markers of
susceptibility to psoriasis and severity of the disease in a
long-term follow-up Brazilian study. Int J Dermatol. 49:1133–1140.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nair RP, Henseler T, Jenisch S, Stuart P,
Bichakjian CK, Lenk W, Westphal E, Guo SW, Christophers E, Voorhees
JJ and Elder JT: Evidence for two psoriasis susceptibility loci
(HLA and 17q) and two novel candidate regions (16q and 20p) by
genome-wide scan. Hum Mol Genet. 6:1349–1356. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Enlund F, Samuelsson L, Enerbäck C, Inerot
A, Wahlström J, Yhr M, Torinsson A, Martinsson T and Swanbeck G:
Analysis of three suggested psoriasis susceptibility loci in a
large Swedish set of families: Confirmation of linkage to
chromosome 6p (HLA region) and to 17q, but not to 4q. Hum Hered.
49:2–8. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang XJ, He PP, Wang ZX, Zhang J, Li YB,
Wang HY, Wei SC, Chen SY, Xu SJ, Jin L, et al: Evidence for a major
psoriasis susceptibility locus at 6p21 (PSORS1) and a novel
candidate region at 4q31 by genome-wide scan in Chinese hans. J
Invest Dermatol. 119:1361–1366. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Genetic Analysis of Psoriasis Consortium
& the Wellcome Trust Case Control Consortium 2. Strange A,
Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band
G, Bellenguez C, et al: A genome-wide association study identifies
new psoriasis susceptibility loci and an interaction between HLA-C
and ERAP1. Nat Genet. 42:985–990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang XJ, Huang W, Yang S, Sun LD, Zhang
FY, Zhu QX, Zhang FR, Zhang C, Du WH, Pu XM, et al: Psoriasis
genome-wide association study identifies susceptibility variants
within LCE gene cluster at 1q21. Nat Genet. 41:205–210. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu KJ, Lv YM, Yin XY, Wang ZX, Sun LD, He
SM, Cheng H, Hu DY, Zhang Z, Li Y, et al: Psoriasis regression
analysis of MHC loci identifies shared genetic variants with
vitiligo. PloS One. 6:e230892011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Capon F, Bijlmakers MJ, Wolf N, Quaranta
M, Huffmeier U, Allen M, Timms K, Abkevich V, Gutin A, Smith R, et
al: Identification of ZNF313/RNF114 as a novel psoriasis
susceptibility gene. Hum Mol Genet. 17:1938–1945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cargill M, Schrodi SJ, Chang M, Garcia VE,
Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese
JJ, et al: A large-scale genetic association study confirms IL12B
and leads to the identification of IL23R as psoriasis-risk genes.
Am J Hum Genet. 80:273–290. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nair RP, Ruether A, Stuart PE, Jenisch S,
Tejasvi T, Hiremagalore R, Schreiber S, Kabelitz D, Lim HW,
Voorhees JJ, et al: Polymorphisms of the IL12B and IL23R genes are
associated with psoriasis. J Invest Dermatol. 128:1653–1661. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chien AL, Elder JT and Ellis CN:
Ustekinumab: A new option in psoriasis therapy. Drugs.
69:1141–1152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gandhi M, Alwawi E and Gordon KB: Anti-p40
antibodies ustekinumab and briakinumab: blockade of interleukin-12
and interleukin-23 in the treatment of psoriasis. Seminars in
cutaneous medicine and surgery. 29:48–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Griffiths CE, Strober BE, van de Kerkhof
P, Ho V, Fidelus-Gort R, Yeilding N, Guzzo C, Xia Y, Zhou B, Li S,
et al: Comparison of ustekinumab and etanercept for
moderate-to-severe psoriasis. N Engl J Med. 362:118–128. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kurzeja M, Rudnicka L and Olszewska M: New
interleukin-23 pathway inhibitors in dermatology: Ustekinumab,
briakinumab and secukinumab. Am J Clin Dermatol. 12:113–125. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cornely R, Rentero C, Enrich C, Grewal T
and Gaus K: Annexin A6 is an organizer of membrane microdomains to
regulate receptor localization and signalling. IUBMB life.
63:1009–1017. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun LD, Cheng H, Wang ZX, Zhang AP, Wang
PG, Xu JH, Zhu QX, Zhou HS, Ellinghaus E, Zhang FR, et al:
Association analyses identify six new psoriasis susceptibility loci
in the Chinese population. Nature Genet. 42:1005–1009. 2010.
View Article : Google Scholar : PubMed/NCBI
|
